BLB provides research services using top-quality pre-clinical models of liver disease, including liver cirrhosis, cholestatic liver disease & NASH
BLB offers you the possibility to evaluate the efficacy and MOA of your compounds in standardized pre-clinical models of liver disease. Endpoint measurements include, among others, the clinical and physical examination of animals during treatment, characterization of the hepatic and systemic hemodynamics (including evaluation of portal pressure and intrahepatic microvascular function), biochemical analysis in plasma, tissue analysis (mRNA, protein, histology, fibrosis, etc), and analysis of the phenotype of the different hepatic cells sub-populations isolated from treated-animals.
BLB HAS THE FOLLOWING IN VIVO ANIMALS MODEL ALWAYS AVAILABLE
CHRONIC LIVER DISEASE
FATTY LIVER DISEASE
TRANSPLANTATION AND REGENERATION
The complete pre-clinical Solution
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers